Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Ann Rheum Dis
; 74(6): 1138-44, 2015 Jun.
Article
in En
| MEDLINE
| ID: mdl-25269831
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Polyethylene Glycols
/
Behcet Syndrome
/
Interferon-alpha
/
Adrenal Cortex Hormones
/
T-Lymphocytes, Regulatory
/
Th17 Cells
/
Immunosuppressive Agents
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Rheum Dis
Year:
2015
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom